IDiyas

For the Inventor, By the Inventor

Danbury, CT, United States of America

Zhaoming Xiong

USPTO Granted Patents = 16


 

Average Co-Inventor Count = 8.7

ph-index = 3

Forward Citations = 34(Granted Patents)


Location History:

  • Danbury, CT (US) (2006 - 2009)
  • Brookfield, CT (US) (2010 - 2014)
  • Ridgefield, CT (US) (2018 - 2021)

Company Filing History:

goldMedal9 out of 1,535 
 
Boehringer Ingelheim International Gmbh
 patents
silverMedal7 out of 276 
 
Boehringer Ingelheim Pharmaceuticals, Inc.
 patents

Years Active: 2006-2021

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):
1. 10954215 - Compounds as modulators of ROR gamma (2021-03-23),
2. 10570118 - Isoquinolones as BTK inhibitors (2020-02-25),
3. 10450314 - Pteridine derivatives as modulators of ROR gamma (2019-10-22),
4. 10131642 - Aldosterone synthase inhibitors (2018-11-20),
5. 8785489 - Heteroaryl substituted indole compounds useful as MMP-13 inhibitors (2014-07-22),
6. 8729114 - Heteroaryl nitrile compounds useful as inhibitors of Cathepsin-S (2014-05-20),
7. 8637550 - Heteroaryl diamide compounds useful as MMP-13 inhibitors (2014-01-28),
8. 8552205 - Derivatives of 6,7-dihydro-5H-imidazo[1,2-alpha]imidazole-3-carboxylic acid amides (2013-10-08),
9. 8299123 - CCR10 antagonists (2012-10-30),
10. 7790712 - Substituted [1,4]diazepino[1,2-A]indoles and azepino[1,2-A]indoles as anti-cytokine inhibitors (2010-09-07),
11. 7592332 - Cytokine inhibitors (2009-09-22),
12. 7550461 - Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases (2009-06-23),
13. 7470692 - Cytokine inhibitors (2008-12-30),
14. 7335657 - Cytokine inhibitors (2008-02-26),
15. 7285545 - Cytokine inhibitors (2007-10-23),

Title: Zhaoming Xiong: Innovator in Pharmaceutical Compounds

Introduction

Zhaoming Xiong is a prominent inventor based in Danbury, CT (US), known for his significant contributions to the field of pharmaceuticals. With a total of 16 patents to his name, he has made remarkable advancements in the modulation of various biological pathways.

Latest Patents

Among his latest patents, Zhaoming Xiong has developed compounds as modulators of ROR gamma. This invention encompasses compounds of a specific formula that are suitable for the modulation of RORγ and the treatment of diseases related to this modulation. Additionally, he has patented isoquinolones as Bruton's tyrosine kinase (BTK) inhibitors. This invention includes compounds that are effective in treating diseases associated with BTK, along with processes for their synthesis and pharmaceutical preparations.

Career Highlights

Zhaoming Xiong has worked with notable companies such as Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc. His work in these organizations has contributed to the development of innovative therapeutic solutions.

Collaborations

Throughout his career, Zhaoming has collaborated with esteemed colleagues, including Donghong Amy Gao and Daniel R Goldberg. These partnerships have further enhanced his research and development efforts in the pharmaceutical industry.

Conclusion

Zhaoming Xiong's innovative work in pharmaceutical compounds showcases his dedication to advancing medical science. His contributions continue to impact the treatment of various diseases, highlighting the importance of research and innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…